@brightfocus.bsky.social
BrightFocus funds groundbreaking research in an urgent effort to discover cures for Alzheimer's disease, macular degeneration and glaucoma.
Tune in today (Oct 8) for our next Glaucoma Chat featuring Dr. Astrid Werner to learn what causes dry eye, how to recognize the symptoms, and effective treatment options—including preservative-free drops, artificial tears, and eyelid care routines.
🔊 Listen live: https://bit.ly/3KzA0eK.
Promotional poster for Glaucoma Chats featuring Astrid Werner, MD, hosted by the BrightFocus Foundation and the American Glaucoma Society. Event scheduled for Wednesday, October 8 at 1:00 pm Eastern. Includes a portrait of Astrid Werner smiling.
Join us for our next Glaucoma Chat on Wednesday, Oct 8, featuring Dr. Astrid Werner to learn what causes dry eye, how to recognize the symptoms, and effective treatment options—including preservative-free drops, artificial tears, and eyelid care routines.
Register today: https://bit.ly/46v9zQ2.
Graphic for a live event titled "Zoom In on Dementia & Alzheimer's: U.S. POINTER Research Improves Cognition in Older Adults" scheduled for October 2 at 1 p.m. ET / 10 a.m. PT. Features an image of Laura Baker, PhD, Professor of Gerontology and Geriatric Medicine.
Tune in to tomorrow's episode of Zoom In on Dementia & Alzheimer’s.
Dr. Laura Baker will share results from the U.S. POINTER trial—the largest study of its kind to test how lifestyle changes impact brain health: https://www.youtube.com/live/eh7EwYm11zY
📢 Our 2025 annual report is here!
Thanks to donors, BrightFocus Foundation funded 186 research grants in 16 countries advancing the fight against Alzheimer's, macular degeneration & glaucoma.
Read the full report: https://bit.ly/4nD6rrp
Graphic for a clinical research webinar titled "Zoom In on Dementia & Alzheimer's" discussing how lifestyle modification significantly improves cognition in older adults. Scheduled for October 2 at 1 p.m. ET. Features a registration link and a photo of Professor Laura Baker, PhD from Wake Forest University School of Medicine. Includes logos for BrightFocus Foundation and Alzheimer's Disease Research. Also indicates an "Ask Questions LIVE!" interactive feature, supported by sponsors including Zoom, Lilly, and Genentech.
Can your lifestyle choices protect your memory? New findings from the U.S. POINTER trial suggest they can.
Join us on Oct 2 to learn how combining key lifestyle strategies could be your best defense against dementia.
Register: https://bit.ly/4pHZNle
Graphic for Macular Chats, an event by BrightFocus Foundation on September 24 at 1:00 pm to discuss geographic atrophy.
Can doctor's slow geographic atrophy progression? Retina specialist Dr. Sara Fard has answers. Join our Macular Chat tomorrow (Sept. 24) at 1 p.m. ET.
Listen live 🔊 https://bit.ly/46cyZlj
📢 BrightFocus Foundation is proud to welcome Jimmy Liu, PhD, as our new Director of Vision Science Programs!
Dr. Liu brings deep expertise in eye disease research and a passion for advancing the next generation of treatments for macular degeneration and glaucoma.
Read more: https://bit.ly/4mjop0x
Join us for our Sept 24 Macular Chat featuring Dr. Sara Fard, a retina specialist at Illinois Retina Associates, as she explains the benefits of sustained GA treatment, including slowing the rate of vision loss, protecting retinal tissue & supporting visual function. Details: https://bit.ly/4miH393
18.09.2025 02:52 — 👍 2 🔁 1 💬 0 📌 0Glaucoma affects more than 4 million Americans & can only be diagnosed through a dilated eye exam—yet too many people don’t know they have glaucoma until irreversible vision loss has occurred.
Our new "Stop Glaucoma” PSA encourages everyone to protect their sight: https://bit.ly/46q9jQS
Age-related macular degeneration (AMD) affects millions and can only be diagnosed through eye exams. Many don't know they have it until irreversible vision loss has already occurred.
Watch our new PSA featuring first-person accounts of vision loss.
Join us to #StopAMD: https://bit.ly/4na8QK1
Dr. Keith Hengen is taking a new approach to Alzheimer's research by studying early brain activity patterns during sleep.
Join us on Sept 18 at noon ET on Instagram Live for a conversation about his Alzheimer's research + answers to your questions.
Read more: https://bit.ly/3Kme46I.
Despite high risk, people with Down Syndrome are excluded from Alzheimer's trials. Inclusive research will increase their life expectancy by 5 years & reduce care costs.
Read about the research co-funded by BrightFocus Foundation and published in @alzdemjournals.bsky.social: https://bit.ly/42rTojT
Attention scientists: Join BrightFocus Foundation for #AlzFastTrack—an official pre-meeting for #SfN25.
⌛ Registration closes Sept 15, 2025!
Learn from experts in the Alzheimer’s and dementia field, network, and grow your grant writing skills.
Register: https://bit.ly/4gcAMtQ
What if vision loss from glaucoma could be restored?
Find out today at 1pm ET, when Dr. Lucy Shen of Mass. Eye and Ear breaks down where the science stands on vision restoration.
Watch our livestream to learn about the latest advances in optic nerve regeneration and stem cell and gene therapies. ⤵️
Quote about the excitement over non-invasive neuromodulation therapy for Alzheimer's, featuring Dr. Giacomo Koch, a BrightFocus Foundation Alzheimer's Disease Research grant recipient.
A treatment being tested in clinical trials for mild-to-moderate Alzheimer's using personalized, non-invasive brain stimulation shows promise in slowing cognitive decline and preserving daily function.
Read about Dr. Giacomo Koch's research: https://bit.ly/41Jr4JG 🧠 🔬
Dr. Roberta Diaz Brinton from the @uazhealthsciences.bsky.social discusses the ReGenBRAIN clinical trial and the potential for harnessing the brain's natural growth processes for the treatment of Alzheimer’s.
Learn more & watch our full episode: https://bit.ly/3JQKxSw
#Science #Health #Alzheimers
Graphic featuring a wooden spoon full of sugar over a background of granulated sugar. Text reads 'Sugar and Age-Related Macular Degeneration', with the BrightFocus Foundation logo.
The connection between sugar and age-related macular degeneration is stronger than you might think.
Research indicates that high-glycemic foods like soda, candy, white bread, and pasta create inflammatory compounds that can harm your retina.
Read more: https://bit.ly/465PeiL.
We're hosting an Instagram Live on Sept 18 at 12 pm ET with Dr. Sharyn Rossi, senior director neuroscience at BrightFocus Foundation & Dr. Keith Hengen of @uwdeptmedicine.bsky.social.
We'll cover sleep and brain health, new research & answer your questions live on Instagram.
Set your reminder. 🔔
Graphic for a webinar titled "Zoom In on Dementia & Alzheimer's: Non-Invasive Light and Sound Stimulation Therapy in Alzheimer's - Update on HOPE Study", scheduled for September 18 at 1 p.m. ET. Invites participants to ask questions live.
Join us for an update on the HOPE Study, which is testing whether non-invasive 40 Hz light and sound stimulation can slow Alzheimer’s.
We’ll explore what the science shows so far and take your questions about this and other non-invasive dementia treatments. Register now: https://bit.ly/3HZvJR0.
📢 #BreakingNews: The FDA has approved an at-home version of Leqembi, the first anti-amyloid therapy individuals can self-administer with a weekly injection.
This new option makes treatment more convenient for families & continues to target harmful brain plaques that drive Alzheimer’s.
Read more. ⤵️
A next-generation blood test could personalize Alzheimer's treatment by revealing disease progression—not just diagnosis.
BrightFocus Foundation grant recipient, Dr. Gemma Salvadó, helped validate this test to identify ideal candidates for anti-amyloid therapies.
🔬 Full story ⬇️
Graphic for a Macular Chats webinar titled "Innovative Science Driving Macular Degeneration Awareness" scheduled for August 27. The image features headshots of two speakers, Dr. Diane Bovenkamp and Dr. Sharyn Rossi, both of BrightFocus Foundation.
Join us live TODAY at 1 p.m. ET for a conversation with BrightFocus Foundation Scientific Affairs teammates Dr. Diane Bovenkamp and Dr. Sharyn Rossi as they discuss this year's Macular Degeneration Research bold and innovative projects.
To tune in, visit: https://bit.ly/4mAxIdG.
Promotional graphic for a live webinar, titled: "Understanding Alzheimer's and Exploring New Frontiers in Treatment." with a photo of Lauren Miller Rogen walking with her mother, Adele. BrightFocus Foundation logo and Focused Ultrasound Foundation logo.
Join us for a 1-hour panel discussion with leaders in the fight against Alzheimer's.
This conversation is inspired by Taking Care, a documentary following the journey of Seth Rogen and Lauren Miller Rogen as they navigate Lauren's mother's advancing Alzheimer's.
Register: https://bit.ly/4lH7bdc
Macular Chats Innovative Science Driving Macular Degeneration Progress Featuring Guest Experts: Dr. Diane Bovenkamp, PhD and Dr. Sharyn Rossi, PhD
BrightFocus Foundation recently awarded $3.8 million to researchers advancing bold ideas to understand, prevent, and treat macular degeneration worldwide.
Join @dianebovenkamp.bsky.social and Sharyn Rossi, PhD as they discuss this year's innovative projects.
Live on 8/27 at 1 pm ET: bit.ly/3UBbzj0
BrightFocus Alzheimer’s Disease Research-funded scientists are developing a home-based brain stimulation treatment that targets memory & mood—all without medication.
Learn how this bold new approach could improve quality of life for people living with Alzheimer’s & their families: bit.ly/47xlAFp.
Mengya Zhao, PhD, a BrightFocus National Glaucoma Research grant recipient, uses innovative models to study neuronal resilience to glaucoma.
Her findings could reveal survival signals in resistant retinal ganglion cells & guide therapies to protect more sensitive ones.
Read more: bit.ly/4m3YdaT 🔬
Think it’s just aging? Why dementia is missed for 3.5 years on average ucl.ac.uk/news/2025/ju... via @ucl.ac.uk
#Alzheimers #dementia #health #wellness
How Targeting a Molecular 'Switch' Could Inspire New Macular Degeneration Treatments. Photo of BrightFocus Foundation Macular Degeneration Research grant recipient Dr. Sandeep Moothedath Subrahmanian.
Dr. Sandeep Moothedath Subrahmanian of Penn State College of Medicine is studying how a “molecular switch” causes a stress response protein, REDD1, to build up and damage retinal cells in early macular degeneration.
His goal: to stop the disease before vision is lost.
Read more: bit.ly/47jUpxN
Red weights next to a model of a brain. Text reads: Breaking News Dispatch: New Discoveries in Alzheimer's Prevention, Diagnosis, and Treatment
From lifestyle changes that protect memory and cutting-edge blood tests to evidence that past lead exposure can impact brain health decades later—major findings at #AAIC2025 are shaping the future of Alzheimer's prevention, diagnosis, and care.
Learn more: bit.ly/3HhDLnO
Join Dr. Amy Zhang from the University of Michigan Kellogg Eye Center on Aug 13 at 1pm ET to discover why proactive glaucoma care matters.
We'll discuss cutting-edge options like minimally invasive surgery, at-home pressure monitoring, and continuous drug delivery systems.
Learn more. ⬇️
